Bevacizumab
Drug / Medication
The most frequently prescribed oncology drug, which impacts blood vessels in tumors and can prolong survival in colorectal cancer by about 4.5 months when combined with other regimens.
Mentioned in 2 videos
Save the 2 videos on Bevacizumab to your own pod.
Sign up free to keep building your knowledge base on Bevacizumab as more episodes are added.
Videos Mentioning Bevacizumab
177 - The development of cancer immunotherapy and its promise for treating advanced cancers
Peter Attia MD
The most frequently prescribed oncology drug, which impacts blood vessels in tumors and can prolong survival in colorectal cancer by about 4.5 months when combined with other regimens.
#133 - Vinay Prasad, M.D., M.P.H: Hallmarks of successful cancer policy
Peter Attia MD
An anti-VEGF compound initially approved for colon cancer. It extends survival by only a couple of months at a high cost, leading some countries to refuse to pay for it.